about
A Meta-Analysis of Randomized Clinical Trials Comparing Shorter (Less or Equal Than 6 Months) and Longer (More or Equal Than 12 Months) Dual Anti-Platelet Therapy Following Drug-Eluting Coronary StentsThe polypill approach - An innovative strategy to improve cardiovascular health in Europe.Efficacy and safety of vorapaxar for the prevention of adverse cardiac events in patients with coronary artery disease: a meta-analysis.Associations of P2Y12R gene polymorphisms with susceptibility to coronary heart disease and clinical efficacy of antiplatelet treatment with clopidogrel.
P2860
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh
2015年學術文章
@zh-hant
name
Dual antiplatelet therapy for coronary artery disease.
@en
type
label
Dual antiplatelet therapy for coronary artery disease.
@en
prefLabel
Dual antiplatelet therapy for coronary artery disease.
@en
P356
P1433
P1476
Dual antiplatelet therapy for coronary artery disease.
@en
P2093
Cheol Whan Lee
P304
P356
10.1253/CIRCJ.CJ-14-1348
P577
2015-01-07T00:00:00Z